A 38-year-old woman with BRCA1 mutation and strong family history of breast and ovarian cancer (mother and sister both affected) undergoes bilateral prophylactic mastectomy. Final pathology unexpectedly reveals a 0.6 cm focus of ductal carcinoma in situ (DCIS) in the right breast, high-grade, with clear margins. She has not yet undergone risk-reducing salpingo-oophorectomy. She desires breast reconstruction. Evaluate the comprehensive management strategy.
Q2
A 56-year-old man with locally advanced pancreatic adenocarcinoma (4 cm head mass with superior mesenteric vein involvement) completes 6 months of FOLFIRINOX with excellent response. Restaging CT shows tumor reduction to 2.5 cm with persistent vessel abutment but no encasement. CA 19-9 decreased from 850 to 45. The multidisciplinary team discusses resectability. The patient is medically fit but anxious about surgical complications. Evaluate the surgical decision-making approach.
Q3
A 42-year-old woman undergoes excisional biopsy of a 1.8 mm Breslow depth melanoma of the right shoulder by an outside provider. Pathology shows ulceration, 3 mitoses/mm², no lymphovascular invasion, and positive deep margin. She presents for further management. Sentinel lymph node biopsy shows 1 of 3 nodes positive with 0.8 mm focus of metastasis. PET-CT shows no distant disease. Evaluate the optimal surgical management strategy.
Q4
A 71-year-old woman with a 7 cm hepatocellular carcinoma in segments 7-8 of the liver has Child-Pugh A cirrhosis, normal bilirubin, platelet count of 95,000/μL, and MELD score of 9. CT shows patent portal vein, no extrahepatic disease, and future liver remnant of 35% after proposed resection. Hepatic vein reconstruction would be required. Analyze the key factor that should most influence the surgical decision.
Q5
A 67-year-old man undergoes low anterior resection for rectal adenocarcinoma. Intraoperatively, the tumor is found to be adherent to the bladder wall. The surgeon performs en bloc resection including partial cystectomy. Final pathology shows a pT4b tumor with the bladder wall involvement being inflammatory adhesions without malignant invasion. Analyze the appropriateness of the surgical decision.
Q6
A 48-year-old woman presents with a 1.2 cm papillary thyroid carcinoma discovered incidentally during thyroid ultrasound for dysphagia. Fine needle aspiration confirms papillary thyroid carcinoma. There is no lymphadenopathy on ultrasound, no family history of thyroid cancer, and no history of radiation exposure. The patient is anxious and requests the most definitive treatment. Analyze the most evidence-based surgical approach.
Q7
A 55-year-old man with a newly diagnosed 3.5 cm gastric adenocarcinoma at the gastroesophageal junction undergoes staging laparoscopy before planned neoadjuvant therapy. During laparoscopy, multiple small peritoneal nodules are visualized. Frozen section confirms metastatic adenocarcinoma. The patient remains asymptomatic with good oral intake. How should the surgical plan be modified?
Q8
A 62-year-old woman with a 4 cm soft tissue mass in the posterior thigh undergoes core needle biopsy showing high-grade pleomorphic sarcoma. MRI shows the mass is adjacent to but not invading the sciatic nerve and femoral vessels. PET-CT shows no distant metastases. What is the most appropriate initial surgical approach?
Q9
A 45-year-old man undergoes right hemicolectomy for a T3N1 adenocarcinoma of the ascending colon. The surgical specimen contains 8 lymph nodes, with 2 showing metastatic disease. The surgeon is reviewing the adequacy of the oncologic resection. What is the minimum total number of lymph nodes that should be examined to adequately stage this colon cancer?
Q10
A 58-year-old woman undergoes wide local excision of a 2.5 cm invasive ductal carcinoma of the left breast with sentinel lymph node biopsy. Final pathology reveals a 2.3 cm tumor with clear margins (closest margin 3 mm), ER-positive, PR-positive, HER2-negative, and 1 of 3 sentinel nodes positive for metastasis. What is the most appropriate next step in surgical management?
Oncologic Surgery Principles US Medical PG Practice Questions and MCQs
Question 1: A 38-year-old woman with BRCA1 mutation and strong family history of breast and ovarian cancer (mother and sister both affected) undergoes bilateral prophylactic mastectomy. Final pathology unexpectedly reveals a 0.6 cm focus of ductal carcinoma in situ (DCIS) in the right breast, high-grade, with clear margins. She has not yet undergone risk-reducing salpingo-oophorectomy. She desires breast reconstruction. Evaluate the comprehensive management strategy.
A. No additional breast surgery needed; proceed with immediate reconstruction and discuss oophorectomy timing (Correct Answer)
B. Radiation therapy to mastectomy site; delayed reconstruction; oophorectomy after radiation
C. Observation of surgical site; proceed with reconstruction; defer oophorectomy until age 40
D. Re-excision to wider margins; delayed reconstruction after confirming no invasion; immediate oophorectomy
E. Genetic counseling; additional oncologic surgery consultation; defer all additional procedures
Explanation: ***No additional breast surgery needed; proceed with immediate reconstruction and discuss oophorectomy timing***
- A **prophylactic mastectomy** effectively treats incidental **DCIS** when margins are clear, as the entire target tissue has been removed, eliminating the need for further excision.
- For **BRCA1 mutation** carriers, **risk-reducing salpingo-oophorectomy (RRSO)** is a high priority usually recommended between ages 35-40, making its discussion essential in her comprehensive care.
*Radiation therapy to mastectomy site; delayed reconstruction; oophorectomy after radiation*
- **Radiation therapy** is not standard practice following a total mastectomy for **DCIS**, even in high-risk mutation carriers, if the margins are clear.
- **Delayed reconstruction** unnecessarily postpones the patient's aesthetic recovery without providing any oncologic benefit in the setting of non-invasive **DCIS**.
*Observation of surgical site; proceed with reconstruction; defer oophorectomy until age 40*
- While reconstruction is appropriate, deferring the discussion of **oophorectomy** until age 40 is risky for **BRCA1** patients, where the cancer risk rises significantly after age 35.
- **Risk management** for BRCA1 carriers must prioritize the **ovaries and fallopian tubes**, as there are no effective screening methods for ovarian cancer compared to breast cancer.
*Re-excision to wider margins; delayed reconstruction after confirming no invasion; immediate oophorectomy*
- **Re-excision** is impossible and unnecessary because a **total mastectomy** has already removed the breast envelope and the primary site of the DCIS.
- Incidental **DCIS** does not preclude **immediate reconstruction**, and forcing a delay would result in more complex secondary surgeries without improving survival.
*Genetic counseling; additional oncologic surgery consultation; defer all additional procedures*
- **Genetic counseling** has already occurred given the documented **BRCA1 mutation** status; repeating it delays necessary clinical intervention.
- Deferring all additional procedures is inappropriate because the patient is in the optimal window for **prophylactic oophorectomy** and desires reconstruction.
Question 2: A 56-year-old man with locally advanced pancreatic adenocarcinoma (4 cm head mass with superior mesenteric vein involvement) completes 6 months of FOLFIRINOX with excellent response. Restaging CT shows tumor reduction to 2.5 cm with persistent vessel abutment but no encasement. CA 19-9 decreased from 850 to 45. The multidisciplinary team discusses resectability. The patient is medically fit but anxious about surgical complications. Evaluate the surgical decision-making approach.
A. Proceed with pancreaticoduodenectomy with vascular resection given excellent response to therapy
B. Recommend chemoradiation to consolidate response before resection
C. Perform diagnostic laparoscopy to rule out occult metastases before planned resection (Correct Answer)
D. Continue chemotherapy to further downstage before considering surgery
E. Defer surgery and continue chemotherapy as patient remains borderline resectable
Explanation: ***Perform diagnostic laparoscopy to rule out occult metastases before planned resection***
- Prior to high-morbidity surgery such as a **pancreaticoduodenectomy**, a **diagnostic laparoscopy** is standard to detect **occult peritoneal or hepatic micrometastases** not visible on CT.
- In patients with originally **locally advanced** disease or those who have undergone long-term chemotherapy, this step avoids a non-therapeutic **laparotomy** in the 15-30% of cases where occult spread is present.
*Proceed with pancreaticoduodenectomy with vascular resection given excellent response to therapy*
- While the tumor response is favorable, skipping the **staging laparoscopy** risks proceeding with a major resection in the presence of occult **M1 disease**.
- High-risk tumors, especially those with high initial **CA 19-9**, require the most rigorous staging before a complex **Whipple procedure**.
*Recommend chemoradiation to consolidate response before resection*
- **Chemoradiation** is an option for **borderline resectable** cases, but the patient has already shown a significant biochemical and radiological response to **FOLFIRINOX**.
- Continuing with local therapy without first excluding **systemic progression** (via laparoscopy) may delay necessary definitive surgery if the disease is currently resectable.
*Continue chemotherapy to further downstage before considering surgery*
- The patient has already completed **6 months of FOLFIRINOX**, which is the typical maximal duration before cumulative **neurotoxicity** and marrow suppression occur.
- With a **CA 19-9** normalization and radiological downstaging, the patient has reached the peak window for potential **surgical salvage**.
*Defer surgery and continue chemotherapy as patient remains borderline resectable*
- Borderline resectable status after **neoadjuvant chemotherapy** is a primary indication to attempt **surgical intervention** rather than continuing palliative chemotherapy indefinitely.
- **Radiological imaging** often underestimates the degree of response (fibrosis vs. tumor), so surgical exploration is necessary to determine if an **R0 resection** is achievable.
Question 3: A 42-year-old woman undergoes excisional biopsy of a 1.8 mm Breslow depth melanoma of the right shoulder by an outside provider. Pathology shows ulceration, 3 mitoses/mm², no lymphovascular invasion, and positive deep margin. She presents for further management. Sentinel lymph node biopsy shows 1 of 3 nodes positive with 0.8 mm focus of metastasis. PET-CT shows no distant disease. Evaluate the optimal surgical management strategy.
A. Re-excision with 1 cm margins, completion lymph node dissection, adjuvant immunotherapy
B. No re-excision needed as tumor was removed, complete lymph node dissection only
C. Re-excision with 2 cm margins, completion lymph node dissection, adjuvant immunotherapy
D. Re-excision with 2 cm margins, observation of regional nodes, adjuvant immunotherapy (Correct Answer)
E. Wide re-excision with 3 cm margins, completion dissection, isolated limb perfusion
Explanation: ***Re-excision with 2 cm margins, observation of regional nodes, adjuvant immunotherapy***
- For a melanoma with a **Breslow depth** of 1.1–2.0 mm, the consensus guidelines recommend **wide local excision** with a **2 cm margin**; re-excision is mandatory here due to the **positive deep margin**.
- Based on the **MSLT-II trial**, completion lymph node dissection (CLND) is no longer the standard of care for **sentinel lymph node (SLN)** positive patients, as it does not improve **overall survival** compared to **nodal observation** with ultrasound.
*Re-excision with 1 cm margins, completion lymph node dissection, adjuvant immunotherapy*
- A **1 cm margin** is insufficient for a T2 melanoma (1.8 mm); current standards require **2 cm margins** for lesions between 1.01 mm and 2.0 mm deep.
- **Completion lymph node dissection** is avoided in favor of nodal surveillance, as it increases **morbidity (lymphedema)** without providing a survival benefit.
*No re-excision needed as tumor was removed, complete lymph node dissection only*
- **Re-excision** is strictly necessary because the **positive deep margin** indicates residual microscopic disease, which carries a high risk of local recurrence.
- **Complete lymph node dissection** is not recommended for minimal nodal disease (0.8 mm focus) when **serial ultrasound surveillance** is an available management pathway.
*Re-excision with 2 cm margins, completion lymph node dissection, adjuvant immunotherapy*
- While the **2 cm margin** and **adjuvant immunotherapy** are correct components, the inclusion of **completion lymph node dissection** makes this an outdated surgical strategy.
- Modern management focuses on **risk-benefit analysis**, where the lack of survival advantage from CLND makes **observation** the preferred approach for nodal disease.
*Wide re-excision with 3 cm margins, completion dissection, isolated limb perfusion*
- **3 cm margins** are not supported by evidence for this depth and do not improve outcomes compared to **2 cm margins** for T2 lesions.
- **Isolated limb perfusion** is typically reserved for patients with **in-transit metastases** or unresectable local disease, not standard Stage III clinical management.
Question 4: A 71-year-old woman with a 7 cm hepatocellular carcinoma in segments 7-8 of the liver has Child-Pugh A cirrhosis, normal bilirubin, platelet count of 95,000/μL, and MELD score of 9. CT shows patent portal vein, no extrahepatic disease, and future liver remnant of 35% after proposed resection. Hepatic vein reconstruction would be required. Analyze the key factor that should most influence the surgical decision.
A. The patient's Child-Pugh score indicates adequate hepatic reserve
B. The need for vascular reconstruction increases operative risk
C. The future liver remnant percentage is inadequate for cirrhotic liver (Correct Answer)
D. The tumor size exceeds Milan criteria for transplantation
E. The platelet count suggests portal hypertension
Explanation: ***The future liver remnant percentage is inadequate for cirrhotic liver***
- In patients with **Child-Pugh A cirrhosis**, a **Future Liver Remnant (FLR)** of at least **40%** is generally required to prevent **post-hepatectomy liver failure**, making 35% insufficient.
- While non-cirrhotic patients can tolerate an FLR as low as 20-25%, the limited **regenerative capacity** and underlying dysfunction of a cirrhotic liver necessitate a larger volume.
*The patient's Child-Pugh score indicates adequate hepatic reserve*
- A **Child-Pugh A** score is a prerequisite for resection but does not guarantee safety if the **surgical volume** being removed is too large.
- Clinical assessment must integrate volume (FLR) with function; score alone cannot override the risk of **postoperative hepatic insufficiency**.
*The need for vascular reconstruction increases operative risk*
- While **hepatic vein reconstruction** adds technical complexity and increases **operative time**, it is not the primary physiological contraindication in this scenario.
- Modern surgical techniques allow for vascular reconstruction provided the **hepatic reserve** is preserved to handle the metabolic demand.
*The tumor size exceeds Milan criteria for transplantation*
- Being outside **Milan criteria** (single lesion >5 cm) excludes the patient from standard **liver transplantation** protocols but does not inherently contraindicate **resection**.
- Resection is often the preferred primary treatment for large HCCs in patients with preserved liver function and **resectable disease**.
*The platelet count suggests portal hypertension*
- A **platelet count** of 95,000/μL is a surrogate marker for **portal hypertension**, which increases surgical risk and the likelihood of **variceal bleeding**.
- While significant, the **FLR volume** is the most critical quantitative limit in this specific case relative to the planned major resection.
Question 5: A 67-year-old man undergoes low anterior resection for rectal adenocarcinoma. Intraoperatively, the tumor is found to be adherent to the bladder wall. The surgeon performs en bloc resection including partial cystectomy. Final pathology shows a pT4b tumor with the bladder wall involvement being inflammatory adhesions without malignant invasion. Analyze the appropriateness of the surgical decision.
A. Inappropriate - should have performed biopsy first to confirm invasion
B. Appropriate - but only if frozen section had confirmed invasion
C. Appropriate - en bloc resection ensures negative margins in adherent tumors (Correct Answer)
D. Inappropriate - should have separated the tumor from bladder bluntly
E. Inappropriate - bladder involvement mandates neoadjuvant therapy first
Explanation: ***Appropriate - en bloc resection ensures negative margins in adherent tumors***
- In surgical oncology, whenever a tumor is **adherent** to an adjacent organ, an **en bloc resection** is mandatory to ensure an **R0 resection** (microscopically negative margins).
- Intraoperatively, it is impossible to reliably distinguish between **malignant invasion** and **inflammatory adhesions**; thus, resection is justified even if pathology later shows only inflammation.
*Inappropriate - should have performed biopsy first to confirm invasion*
- Performing an **incisional biopsy** or manipulating the tumor-organ interface risks **tumor spillage** and seeding the peritoneal cavity.
- Biopsies in this context do not change the surgical management and may lead to a **false-negative** result if the specimen is not representative.
*Appropriate - but only if frozen section had confirmed invasion*
- **Frozen section** analysis of the interface requires separating the tumor from the bladder, which violates oncologic principles of **no-touch technique** and en bloc removal.
- Relying on frozen sections can lead to **sampling errors** and unnecessarily increases operative time without changing the requirement for negative margins.
*Inappropriate - should have separated the tumor from bladder bluntly*
- **Blunt separation** of an adherent tumor is strictly contraindicated as it often results in **positive surgical margins** and tumor fragmentation.
- Even if the plane appears clear, microscopic **cancer cells** may remain, significantly increasing the risk of **local recurrence**.
*Inappropriate - bladder involvement mandates neoadjuvant therapy first*
- While **neoadjuvant chemoradiotherapy** is standard for locally advanced rectal cancer, once the patient is in the operating room, the goal is **complete resection** of the visible disease.
- Adherence discovered **intraoperatively** requires immediate surgical management via en bloc resection rather than aborting the procedure for medical therapy.
Question 6: A 48-year-old woman presents with a 1.2 cm papillary thyroid carcinoma discovered incidentally during thyroid ultrasound for dysphagia. Fine needle aspiration confirms papillary thyroid carcinoma. There is no lymphadenopathy on ultrasound, no family history of thyroid cancer, and no history of radiation exposure. The patient is anxious and requests the most definitive treatment. Analyze the most evidence-based surgical approach.
A. Total thyroidectomy with prophylactic central neck dissection
B. Active surveillance with serial ultrasounds
C. Thyroid lobectomy with isthmusectomy (Correct Answer)
D. Total thyroidectomy without routine neck dissection
E. Lobectomy with radioactive iodine ablation of remaining lobe
Explanation: ***Thyroid lobectomy with isthmusectomy***
- For **papillary thyroid carcinoma (PTC)** between **1 cm and 4 cm** without high-risk features (no extrathyroidal extension, no lymphadenopathy), **thyroid lobectomy** is considered sufficient and evidence-based treatment.
- This approach significantly reduces the risk of **hypoparathyroidism** and **recurrent laryngeal nerve injury** compared to total thyroidectomy while maintaining equivalent **long-term survival rates**.
*Total thyroidectomy with prophylactic central neck dissection*
- **Prophylactic central neck dissection** (Level VI) is generally not recommended for T1 or T2 tumors in the absence of clinical nodal involvement, as it increases morbidity without improving survival.
- This extensive surgery carries a higher risk of **permanent hypocalcemia** and is reserved for advanced primary tumors or clinically positive nodes.
*Active surveillance with serial ultrasounds*
- **Active surveillance** is typically reserved for **papillary microcarcinomas** (<1 cm) that are low-risk and confined to the thyroid parenchyma.
- Since this lesion is **1.2 cm**, surgical intervention is generally the standard of care to prevent potential local progression.
*Total thyroidectomy without routine neck dissection*
- While **total thyroidectomy** is an option for tumors >1 cm, it is no longer strictly mandated for tumors <4 cm if they are **low-risk** and unifocal.
- Choosing this over lobectomy necessitates lifelong **levothyroxine replacement therapy** and increases the surgical side-effect profile without a proven oncological benefit in this specific patient.
*Lobectomy with radioactive iodine ablation of remaining lobe*
- **Radioactive iodine (RAI)** ablation is ineffective if the contralateral lobe remains, as the thyroid tissue will preferentially uptake the iodine instead of any residual microscopic cancer cells.
- RAI therapy requires a **total thyroidectomy** to be performed first to ensure the target is only the residual thyroid bed or metastatic sites.
Question 7: A 55-year-old man with a newly diagnosed 3.5 cm gastric adenocarcinoma at the gastroesophageal junction undergoes staging laparoscopy before planned neoadjuvant therapy. During laparoscopy, multiple small peritoneal nodules are visualized. Frozen section confirms metastatic adenocarcinoma. The patient remains asymptomatic with good oral intake. How should the surgical plan be modified?
A. Proceed with gastrectomy for debulking and symptom control
B. Perform palliative gastrojejunostomy to prevent future obstruction
C. Abort procedure and recommend systemic chemotherapy (Correct Answer)
D. Convert to open laparotomy for complete staging and cytoreduction
E. Place feeding jejunostomy tube for nutritional support
Explanation: ***Abort procedure and recommend systemic chemotherapy***
- Staging laparoscopy revealed **peritoneal metastases (M1 disease)**, which classifies the cancer as Stage IV and makes surgical resection non-curative.
- As the patient is **asymptomatic** and maintaining good oral intake, there is no immediate indication for surgery, and the standard of care is **systemic palliative chemotherapy**.
*Proceed with gastrectomy for debulking and symptom control*
- **Cytoreductive surgery** or debulking has not been shown to provide a survival benefit in metastatic gastric adenocarcinoma.
- Gastrectomy in the presence of **M1 disease** carries a high risk of morbidity without improving the patient's long-term outcome when they are currently asymptomatic.
*Perform palliative gastrojejunostomy to prevent future obstruction*
- Prophylactic palliative bypass is not recommended for patients who are currently **tolerating oral intake** without symptoms of obstruction.
- Modern **endoscopic stenting** is often preferred over surgical bypass if obstructive symptoms develop later in the disease course.
*Convert to open laparotomy for complete staging and cytoreduction*
- Conversion to **laparotomy** is unnecessary once metastasis is confirmed via laparoscopy, as it increases surgical trauma without changing the management plan.
- **Complete cytoreduction** is not a standard treatment for metastatic gastric cancer and is generally reserved for highly specific clinical trials involving HIPEC.
*Place feeding jejunostomy tube for nutritional support*
- A **feeding jejunostomy** is not indicated as the patient has **good oral intake** and is not currently experiencing nutritional failure or severe dysphagia.
- Unnecessary tubes can decrease the patient's **quality of life** and are associated with complications like site infection or bowel obstruction.
Question 8: A 62-year-old woman with a 4 cm soft tissue mass in the posterior thigh undergoes core needle biopsy showing high-grade pleomorphic sarcoma. MRI shows the mass is adjacent to but not invading the sciatic nerve and femoral vessels. PET-CT shows no distant metastases. What is the most appropriate initial surgical approach?
A. Wide local excision with 1-2 cm margins followed by radiation
B. Amputation to ensure complete tumor removal
C. Neoadjuvant radiation followed by wide excision with negative margins (Correct Answer)
D. Marginal excision followed by adjuvant chemotherapy
E. Excisional biopsy followed by treatment planning
Explanation: ***Neoadjuvant radiation followed by wide excision with negative margins***
- For a **high-grade pleomorphic sarcoma**, providing **neoadjuvant radiation** helps shrink the tumor core and defines a pseudo-capsule, facilitating a **limb-sparing wide excision**.
- This approach is preferred for tumors adjacent to neurovascular bundles to maximize the chance of achieving **R0 resection** (negative margins) while preserving function.
*Wide local excision with 1-2 cm margins followed by radiation*
- While **adjuvant radiation** is an option, neoadjuvant therapy is often preferred for high-grade lesions to reduce the total **radiation field** and volume.
- Performing surgery first may increase the risk of positive margins when the tumor is in close proximity to the **sciatic nerve** and **femoral vessels**.
*Amputation to ensure complete tumor removal*
- **Amputation** is no longer the standard of care for sarcomas unless the tumor extensively involves major nerves or blood vessels that cannot be reconstructed.
- Modern **limb-salvage surgery** combined with radiation yields equivalent survival rates compared to radical amputation.
*Marginal excision followed by adjuvant chemotherapy*
- **Marginal excision** (cutting through the reactive zone) is insufficient for high-grade sarcomas as it results in a high risk of **local recurrence**.
- The role of **adjuvant chemotherapy** in soft tissue sarcomas is controversial and secondary to achieving local control through wide surgical margins.
*Excisional biopsy followed by treatment planning*
- **Excisional biopsy** is inappropriate for a 4 cm mass; it disrupts tissue planes and often leads to **contaminated surgical beds**, necessitating more extensive definitive surgery.
- Diagnosis should always be established first via **core needle biopsy** before any definitive surgical intervention is planned.
Question 9: A 45-year-old man undergoes right hemicolectomy for a T3N1 adenocarcinoma of the ascending colon. The surgical specimen contains 8 lymph nodes, with 2 showing metastatic disease. The surgeon is reviewing the adequacy of the oncologic resection. What is the minimum total number of lymph nodes that should be examined to adequately stage this colon cancer?
A. At least 6 lymph nodes
B. At least 15 lymph nodes
C. At least 12 lymph nodes (Correct Answer)
D. At least 8 lymph nodes
E. At least 20 lymph nodes
Explanation: ***At least 12 lymph nodes***
- Current oncologic guidelines from the **AJCC** and **NCCN** establish that a minimum of **12 lymph nodes** must be examined to ensure accurate pathological staging of colon cancer.
- Examining fewer than 12 nodes increases the risk of **understaging** (missing occult metastatic disease), which can negatively impact survival outcomes and decisions regarding **adjuvant chemotherapy**.
*At least 6 lymph nodes*
- This number is significantly below the standard of care and is statistically insufficient to achieve a **90% confidence level** for identifying nodal metastasis.
- Suboptimal nodal yield like this is considered a **high-risk feature** in Stage II disease, often necessitating more aggressive treatment.
*At least 15 lymph nodes*
- While some studies suggest higher yields improve prognostic accuracy, **15 nodes** is not the current mandatory minimum requirement for standard staging.
- A yield of 15 or more may reflect superior **surgical technique** or **pathological harvesting**, but it is not the threshold used to define an "adequate" resection in guidelines.
*At least 8 lymph nodes*
- Although the patient in this scenario had 8 nodes recovered, this is considered **inadequate staging** despite the fact that positive nodes were found.
- An inadequate lymph node count can lead to an underestimate of the **lymph node ratio**, which is a key prognostic indicator in colorectal oncology.
*At least 20 lymph nodes*
- While retrieving **20 nodes** or more is generally desirable and associated with better long-term survival, it is not the **minimum standard** required for staging.
- Setting the bar at 20 would be clinically unrealistic for many specimens, particularly in patients with **older age** or prior radiation therapy.
Question 10: A 58-year-old woman undergoes wide local excision of a 2.5 cm invasive ductal carcinoma of the left breast with sentinel lymph node biopsy. Final pathology reveals a 2.3 cm tumor with clear margins (closest margin 3 mm), ER-positive, PR-positive, HER2-negative, and 1 of 3 sentinel nodes positive for metastasis. What is the most appropriate next step in surgical management?
A. Re-excision to achieve wider margins of at least 1 cm
B. Total mastectomy with immediate reconstruction
C. Proceed directly to adjuvant chemotherapy and radiation (Correct Answer)
D. Completion axillary lymph node dissection
E. Observation with close clinical follow-up
Explanation: ***Proceed directly to adjuvant chemotherapy and radiation***
- Based on the **ACOSOG Z0011 trial**, completion axillary lymph node dissection (ALND) is not required for patients with T1-T2 tumors, fewer than 3 positive sentinel nodes, and planned **whole breast radiation**.
- The current standard for **clear margins** in invasive ductal carcinoma is simply "no ink on tumor," making the 3 mm margin sufficient without further surgery.
*Re-excision to achieve wider margins of at least 1 cm*
- Current surgical guidelines state that for **invasive carcinoma**, a **negative margin** (no ink on tumor) is adequate; 1 cm margins are not required.
- Routine re-excision of clear margins does not improve outcomes and increases surgical morbidity unnecessarily.
*Total mastectomy with immediate reconstruction*
- **Breast-conserving therapy** (lumpectomy plus radiation) has been proven to have equivalent survival rates to mastectomy for early-stage breast cancer.
- Mastectomy is not indicated here as the patient has already achieved clear margins and does not have multicentric disease or contraindications to radiation.
*Completion axillary lymph node dissection*
- While the sentinel node was positive, **ALND** can be safely omitted in this patient because she has a small tumor (<5 cm) and only **one positive node**.
- Omission of ALND avoids the significant risk of **lymphedema** without compromising overall survival when adjuvant systemic therapy and radiation are provided.
*Observation with close clinical follow-up*
- Observation alone is inappropriate because the patient has a **positive lymph node**, which necessitates **adjuvant systemic therapy** to reduce recurrence risk.
- Standard of care for node-positive, hormone-receptor-positive breast cancer involves **radiation** and hormonal or chemotherapy, not just monitoring.
